Vibrantz Technologies prepares for construction launch of facility dedicated to Pearls™ sustainable tinting solution, advancing simpler, more efficient and cost-effective coloring of water-based paints
Vibrantz Technologies has celebrated the upcoming groundbreaking of a new production facility at its Sittard, Netherlands, site to significantly expand the capacity of its patented Pearls™ sustainable tinting solution, a technology package that includes a dispensing machine to volumetrically dose solid colorants to create myriad end-use paint colors. This project is the first in a series of planned optimizations, part of a roughly $20 million investment, that will increase Vibrantz’s global Pearls production capacity to approximately 1.2 million liters per year, and enable the company to more effectively address the sustainability, performance and cost demands of colorant manufacturers and paint retailers globally.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911534283/en/
Left to right: Barry Misquitta, President of Color Solutions at Vibrantz; Michael Wilson, CEO at Vibrantz; Martijn Kunnen, Director of Commercial EMEA and Global Strategy Colorants at Vibrantz; and Hans Verheijen, Mayor of Sittard, Netherlands (Photo: Business Wire)
Pearls, the coatings industry’s first volumetrically dosed tinting system of solid colorants for water-based architectural and industrial paints, is designed for simplicity, sustainability and cost-efficiency, with zero harmful chemicals and fully recyclable packaging. The solution extends paint shelf life, is easier to use than traditional tinting technologies, and contributes to a reduced total cost of ownership for tinting systems.
“Innovation and being responsible environmental stewards remain at the forefront of our growth strategy, fueling our commitment to invest in cutting-edge technologies that help customers solve their most pressing challenges, many of which are rooted in the desire to have a more favorable environmental impact,” said D. Michael Wilson, CEO at Vibrantz. “Breaking ground on a new production facility for Pearls represents a special milestone made possible by years of shared commitment between our Vibrantz team and many early-adopter customers, particularly in Europe, to growth and a more sustainable future. Both the Pearls manufacturing process and the dispensing equipment used in paint stores are remarkable depictions of true innovation, customer partnership and our commitment to bring color, performance and vibrancy to life.”
Vibrantz has secured multiple dispensing equipment partners and numerous in-store users of Pearls and is poised to expand its market presence as demand for efficient and sustainable tinting solutions grows.
“Customers continue driving the ongoing shift toward products that deliver both performance and sustainability,” said Barry Misquitta, president of Color Solutions at Vibrantz. “Pearls is designed to minimize waste, eliminate harmful chemicals and deliver long-term cost savings, qualities that are becoming non negotiables in our industry. This strategic investment underscores Vibrantz’s commitment to growth and our dedication to delivering groundbreaking solutions to customers worldwide.”
Located adjacent to Vibrantz’s existing colorant plant in Sittard, Netherlands, the new facility is expected to be operational in 2026 and will house a full-scale production plant and research and development laboratories. To learn more, contact pearls@vibrantz.com or visit vibrantzpearls.com.
About Vibrantz Technologies
Vibrantz is a leading global provider of specialty chemicals and materials solutions whose purpose is to bring color, performance and vibrancy to life. Our technologies improve the functionality, safety and/or aesthetics of products across an array of applications and make their way into myriad consumer products. With key competencies in particle engineering, glass and ceramic science and color technology, Vibrantz has leading positions in specialty mineral and chemical additives for batteries, electronic components, agriculture and construction; pigments for paints and coatings, thermoset plastics and thermoplastics; and high-performance glass coatings and porcelain enamel solutions. Headquartered in Houston, Texas, the company employs approximately 4,000 people and operates 61 manufacturing sites across six continents. Visit vibrantz.com to learn more.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240911534283/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom